Cargando…
Combined Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Whole Blood
BACKGROUND: Timely identification of a causative pathogen and its antimicrobial susceptibility profile is important for effective therapy. This is especially true in the case of bloodstream infections caused by the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetoba...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631507/ http://dx.doi.org/10.1093/ofid/ofx163.1566 |
_version_ | 1783269490239209472 |
---|---|
author | Andini, Nadya Hu, Anne Yang, Samuel |
author_facet | Andini, Nadya Hu, Anne Yang, Samuel |
author_sort | Andini, Nadya |
collection | PubMed |
description | BACKGROUND: Timely identification of a causative pathogen and its antimicrobial susceptibility profile is important for effective therapy. This is especially true in the case of bloodstream infections caused by the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae) pathogens where inappropriate antibiotic prescription often leads to higher mortality and increased selection for multi-drug resistant strains. However, current standard protocols for pathogen identification (ID) and antimicrobial susceptibility testing (AST) take days to complete and despite the advancement of molecular diagnostics, none can concurrently provide reliable ID and AST information. METHODS: We developed a method of direct ID and AST of ESKAPE pathogens using real-time PCR-HRM (high resolution melt) as the end-point analysis coupled with whole blood sample preparation. Our assay utilizes blood cell lysis, removal of background human DNA and protein, pathogen enrichment, antibiotic exposure, and broad-range PCR-HRM analysis targeting bacterial internal transcribed spacer region to determine ID and AST in less than 10 hours. We then assessed antimicrobial
susceptibility/resistance by calculating the difference in threshold cycle compared with untreated sample (ΔCt), and determined species identity by its melt curve using an automated computer algorithm against a reference curve database of 89 bacterial species. RESULTS: Our assay was able to reach a limit of detection of 10 CFU/mL for all tested ESKAPE organisms except for E. faecium (100 CFU/mL). Using a final concentration of 100 CFU/mL and a calculated ΔCt cutoff value of 1.5, we observed significant ΔCt changes with antibiotic treatment and established minimum inhibitory concentrations (MICs) for each strain. Comparison of the observed values to reference MICs showed overall similar results. Furthermore, our automated machine-learning based computer algorithm was able to correctly identify each organism based on its melt curve. CONCLUSION: Our results suggest that reliable rapid bacterial ID and AST information can be simultaneously obtained directly from whole blood using our combined ID-AST assay. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-5631507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56315072017-11-07 Combined Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Whole Blood Andini, Nadya Hu, Anne Yang, Samuel Open Forum Infect Dis Abstracts BACKGROUND: Timely identification of a causative pathogen and its antimicrobial susceptibility profile is important for effective therapy. This is especially true in the case of bloodstream infections caused by the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae) pathogens where inappropriate antibiotic prescription often leads to higher mortality and increased selection for multi-drug resistant strains. However, current standard protocols for pathogen identification (ID) and antimicrobial susceptibility testing (AST) take days to complete and despite the advancement of molecular diagnostics, none can concurrently provide reliable ID and AST information. METHODS: We developed a method of direct ID and AST of ESKAPE pathogens using real-time PCR-HRM (high resolution melt) as the end-point analysis coupled with whole blood sample preparation. Our assay utilizes blood cell lysis, removal of background human DNA and protein, pathogen enrichment, antibiotic exposure, and broad-range PCR-HRM analysis targeting bacterial internal transcribed spacer region to determine ID and AST in less than 10 hours. We then assessed antimicrobial
susceptibility/resistance by calculating the difference in threshold cycle compared with untreated sample (ΔCt), and determined species identity by its melt curve using an automated computer algorithm against a reference curve database of 89 bacterial species. RESULTS: Our assay was able to reach a limit of detection of 10 CFU/mL for all tested ESKAPE organisms except for E. faecium (100 CFU/mL). Using a final concentration of 100 CFU/mL and a calculated ΔCt cutoff value of 1.5, we observed significant ΔCt changes with antibiotic treatment and established minimum inhibitory concentrations (MICs) for each strain. Comparison of the observed values to reference MICs showed overall similar results. Furthermore, our automated machine-learning based computer algorithm was able to correctly identify each organism based on its melt curve. CONCLUSION: Our results suggest that reliable rapid bacterial ID and AST information can be simultaneously obtained directly from whole blood using our combined ID-AST assay. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631507/ http://dx.doi.org/10.1093/ofid/ofx163.1566 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Andini, Nadya Hu, Anne Yang, Samuel Combined Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Whole Blood |
title | Combined Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Whole Blood |
title_full | Combined Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Whole Blood |
title_fullStr | Combined Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Whole Blood |
title_full_unstemmed | Combined Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Whole Blood |
title_short | Combined Bacterial Identification and Antimicrobial Susceptibility Testing Directly from Whole Blood |
title_sort | combined bacterial identification and antimicrobial susceptibility testing directly from whole blood |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631507/ http://dx.doi.org/10.1093/ofid/ofx163.1566 |
work_keys_str_mv | AT andininadya combinedbacterialidentificationandantimicrobialsusceptibilitytestingdirectlyfromwholeblood AT huanne combinedbacterialidentificationandantimicrobialsusceptibilitytestingdirectlyfromwholeblood AT yangsamuel combinedbacterialidentificationandantimicrobialsusceptibilitytestingdirectlyfromwholeblood |